1 Compelling Reason to Invest in Eli Lilly Stock Immediately
Eli Lilly, a leading pharmaceutical company, has been performing exceptionally well in 2024. Their stock has surged by 58% this year, surpassing the S&P 500 and Nasdaq Composite indexes. This growth can be attributed to their success in the diabetes and obesity care markets with their popular GLP-1 agonists, Mounjaro and Zepbound. In addition, the … Read more